Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstr. 31, D-93053 Regensburg, Germany.
J Med Chem. 2020 Aug 13;63(15):8198-8215. doi: 10.1021/acs.jmedchem.0c00426. Epub 2020 Jul 16.
Within the family of neuropeptide Y (NPY) receptors, the Y receptor (YR) is unique as it prefers pancreatic polypeptide over NPY and peptide YY. Today, low-molecular-weight YR ligands are lacking, in particular antagonists. We synthesized a series of peptidic NPY YR ligands, derived from the hexapeptide acetyl-Arg-Tyr-Arg-Leu-Arg-Tyr-NH (), reported to be a YR partial agonist with high affinity (p YR: 8.43). Peptide was N-terminally extended as well as truncated and subjected to a d-amino acid scan, and Leu was replaced by different amino acids. Compounds were characterized by radioligand competition binding and functional studies (Ca mobilization and β-arrestin 1/2 recruitment). N-terminal truncation of resulted in a tetrapeptide (Arg-Leu-Arg-Tyr-NH), being a YR partial agonist with unchanged YR affinity (p: 8.47). Remarkably, replacement of Leu in and in derivatives of by Trp turned YR agonism to antagonism, giving YR antagonists with p values ≤7.57.
在神经肽 Y (NPY) 受体家族中,Y 受体 (YR) 是独特的,因为它更喜欢胰多肽而不是 NPY 和肽 YY。如今,缺乏低分子量的 YR 配体,特别是拮抗剂。我们合成了一系列肽 NPY YR 配体,衍生自六肽乙酰-精氨酸-酪氨酸-精氨酸-亮氨酸-精氨酸-酪氨酸-NH 2 (),据报道它是一种具有高亲和力的 YR 部分激动剂 (p YR:8.43)。肽 被 N 端延伸和截断,并进行 d-氨基酸扫描,亮氨酸被不同的氨基酸取代。通过放射性配体竞争结合和功能研究 (Ca 动员和β-arrestin 1/2 募集) 对化合物进行了表征。 的 N 端截断导致四肽 (精氨酸-亮氨酸-精氨酸-酪氨酸-NH 2 ),作为 YR 部分激动剂,其 YR 亲和力不变 (p:8.47)。值得注意的是,亮氨酸在 中和 的衍生物中的取代,使 YR 激动作用转变为拮抗作用,得到了 p 值≤7.57 的 YR 拮抗剂。